Bone Metastases from Prostate Cancer : Biology, Diagnosis and Management / / edited by Francesco Bertoldo, Francesco Boccardo, Emilio Bombardieri, Laura Evangelista, Riccardo Valdagni |
Edizione | [1st ed. 2017.] |
Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017 |
Descrizione fisica | 1 online resource (X, 293 p. 63 illus., 40 illus. in color.) |
Disciplina | 616.994 |
Soggetto topico |
Oncology
Urology Nuclear medicine Radiotherapy Orthopedics Pathology Oncology Nuclear Medicine |
ISBN | 3-319-42327-4 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Biology and pathophysiology of bone metastases -- Markers of bone turnover -- Bone homing and metastasis -- Markers of prostate cancer -- Circulating cells -- Radiological assessment of bone metastases -- Nuclear Medicine: bone target imaging -- Nuclear Medicine: cancer and receptor target imaging -- Hormonal therapy -- Chemotherapy -- Combinations of hormonal therapy and chemotherapy -- Surgery -- Radiotherapy -- Bone-targeted agents -- Bone seeking radionuclide for therapy -- New frontiers in treatments -- Approaches for the assessment of response to therapies -- From Symptom control to pain palliation -- Economic impact of prostate cancer bone metastases -- Multidisciplinary approach. . |
Record Nr. | UNINA-9910149481003321 |
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Clinical Applications of Nuclear Medicine Targeted Therapy / / edited by Emilio Bombardieri, Ettore Seregni, Laura Evangelista, Carlo Chiesa, Arturo Chiti |
Edizione | [1st ed. 2018.] |
Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2018 |
Descrizione fisica | 1 online resource (XIV, 503 p. 108 illus., 73 illus. in color.) |
Disciplina | 616.07548 |
Soggetto topico |
Nuclear medicine
Radiotherapy Oncology Hematology Endocrinology Urology Nuclear Medicine Oncology Endocrinology |
ISBN | 3-319-63067-9 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | THYROID DISEASES -- Diagnosis and treatment of hyperthyroidism (Endocrinologist) -- Radiopharmaceuticals for therapy of thyroid diseases ( chemistry, mechanism of uptake, biodistribution, doses) (Radiochemist) -- Radioiodine therapy of hyperthyroidism (indications , procedures and results) ( Nucl Medicine Physician) -- Dosimetry (Physicist) -- Clinical management of thyroid cancer (Oncologist) -- Radioidine therapy of thyroid cancer (ablation, loco-regional and distant metastases, indications procedures and results) (Nucl Medicine Physician) -- Dosimetry (Physicist) -- Novel approaches of radiometabolic treatment of thyroid cancer (Nucl Medicine Physician) -- Published guidelines on radioisotopic treatments of thyroid diseases (Nucl Medicine Physician and Oncologist) -- HEPATIC CANCER -- Clinical options for treatment of hepatocellular carcinoma (HCC) (Oncologist, Surge on) -- Radiopharmaceuticals for radioembolization (characteristics, mechanism of uptake, biodistribution, doses) (Radiochemist) -- HCC radioembolization with 90Y microspheres (indications and procedures) (Nucl Medicine Physician) -- Dosimetry (Physicist) -- The clinical problem of hepatic metastases (Oncologist, Surgeon) -- Radioembolization of hepatic metastases with 90Y microspheres (indications and procedures) (Nucl Medicine Physician) -- Dosimetry (Physicist) -- Published guidelines on radioisotope treatment of hepatocellular cancer (Nucl Medicine Physician and Oncologist) -- NEUROENDOCRINE TUMORS -- Radiopharmaceuticals for treatment of neuroendocrine tumors (mechanisn of action, biodistribution, doses) (Radiochemis inPaediatric tumors of neuroendocrine origin (Oncologist) -- Treatment with 131I – MIBG (indications procedures and results) (Nucl Medicine Physician) -- Dosimetry (Physicist) -- GEP neuroendocrine tumors (Oncologist) -- PPRT with 90Y labeled peptides (indications ,procedures and results) (Nucl Medicine Physician) -- Dosimetry (Physicist) -- Published guidelines on radioisotope treatment of Neuroendocrine tumors(Nucl Medicine Physician and Oncologist) -- LYMPHOMAS -- Selection of lymphoma patients candidates for Radioimmunotherapy (Haematologist) -- Radiopharmaceuticals for treatment of neuroendocrine tumors (mechanisn of action, biodistribution, doses) (Radiochemist) -- Treatment with anti-CD20 Antibodies ( 90Y- ibritumomab /131 I- Tositumomab) (indications and procedures and results) (Nucl Medicine Physician) -- Radioimmunotherapy at high doses of lymphomas (Nucl Medicine Physician) -- Published guidelines on radioisotope treatment of Lymphomas (Nucl Medicine Physician and Oncologist) -- PROSTATE CANCER -- Overview on bone metastases from prostate cancer (Urologist, Oncologist) -- Radiopharmaceuticals for treatment of bone metastases (mechanisn of action, biodistribution, doses) (Radiochemist) -- Targeted therapy with 223Ra dichloride of bone metastases(Nucl Medicine Physician) -- Novel approaches of treatment with 223Ra based targeted therapy (Nucl Medicine Physician) -- Dosimetry (Physicist) -- Published guidelines on radioisotope treatment of Bone Metastases (Nucl Medicine Physician and Oncologist). |
Record Nr. | UNINA-9910300281103321 |
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2018 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Mesothelioma : From Research to Clinical Practice / / edited by Giovanni Luca Ceresoli, Emilio Bombardieri, Maurizio D'Incalci |
Edizione | [1st ed. 2019.] |
Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019 |
Descrizione fisica | 1 online resource (XII, 340 p. 82 illus., 56 illus. in color.) |
Disciplina |
616.994
616.99424 |
Soggetto topico |
Oncology
Nuclear medicine Molecular biology Bioinformatics Human genetics Immunology Oncology Nuclear Medicine Molecular Medicine Human Genetics |
ISBN | 3-030-16884-0 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Epidemiology of mesothelioma -- Asbestos and pathophysiology of mesothelioma -- Screening issues in exposed subjects and early diagnosis -- Genetics and epigenetics of mesothelioma -- Microenvironment and immunology of mesothelioma -- Pre clinical models in mesothelioma -- Pathological diagnosis of mesothelioma -- Tissue and circulating biomarkers in mesothelioma -- Diagnostic imaging of mesothelioma -- Measuring malignant pleural mesothelioma -- Role of metabolic imaging in mesothelioma -- Staging of malignant pleural mesothelioma -- Surgery and multimodality treatment in malignant pleural mesothelioma -- Role of radiotherapy in malignant pleural mesothelioma -- Role of chemotherapy in malignant pleural mesothelioma -- Targeting angiogenesis in mesothelioma -- Targeted therapies in mesothelioma -- Mesothelin-targeting agents in mesothelioma -- Immunotherapy of mesothelioma: vaccines and cell therapy -- Immunotherapy of mesothelioma: immune checkpoints inhibitors -- Peritoneal mesothelioma: diagnosis and management -- Rare localizations of mesothelioma -- Unmet needs and future outlook of mesothelioma management. |
Record Nr. | UNINA-9910337510803321 |
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|